LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- Revenue, 2025
- $268M
- YoY, 2025
- +60.4%
- 5-year CAGR
- +10.4%
- 10-year CAGR
- +14.1%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $268M | +60.4% |
| 2024 | $167M | +27.3% |
| 2023 | $131M | −33.1% |
| 2022 | $196M | −18.8% |
| 2021 | $242M | +47.7% |
| 2020 | $164M | +36.0% |
| 2019 | $120M | −52.2% |
| 2018 | $251M | +78.2% |
| 2017 | $141M | +29.5% |
| 2016 | $109M | +51.5% |
| 2015 | $72M | +11.4% |
| 2014 | $65M | +31.8% |
| 2013 | $49M | +56.0% |
| 2012 | $31M | +4.5% |
| 2011 | $30M | +27.6% |
| 2010 | $24M | −39.6% |
| 2009 | $39M | — |